Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects

Gail Skowron, John Spritzler, Jodi M. Weidler, Gregory K. Robbins, Victoria A. Johnson, Ellen Chan, David M. Asmuth, Rajesh Gandhi, Yolanda Lie, Michael P. Bates, Richard B. Pollard. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. Journal of Acquired Immune Deficiency Syndromes. 2009. 50: 250-8.

Year

2009

Journal

Journal of Acquired Immune Deficiency Syndromes

Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection

Norah Shire, Marepalli B. Rao, Paul Succop, C. Ralph Buncher, Janet Andersen, Adeel A. Butt, Raymond T. Chung, Kenneth E. Sherman. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clinical Gastroenterology and Hepatology. 2009. 7: 471-80.

Year

2009

Journal

Clinical Gastroenterology and Hepatology

The oral HIV/AIDS research alliance: updated case definitions for oral mucosal disease endpoints

Caroline Shiboski, Lauren L. Patton, Jennifer Y. Webster-Cyriaque, Deborah Greenspan, Rana Traboulsi, Mahmoud A. Ghannoum, Richard J. Jurevic, joan A. Phelan, David Reznik, John S. Greenspan. The oral HIV/AIDS research alliance: updated case definitions for oral mucosal disease endpoints. Journal of Oral Pathology and Medicine. 2009. 38: 481-8.

Year

2009

Journal

Journal of Oral Pathology and Medicine

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

Todd Hulgan, John P. Donahue, Laura Smeaton, Minya Pu, Hongying Wang, Michael M. Lederman, Kimberly Y. Smith, Hernan Valdez, Christopher D. Pilcher, David W. Haas. Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. European Journal of Clinical Pharmacology. 2009. 65: 1081-8. PMID: 19779705

Year

2009

Journal

European Journal of Clinical Pharmacology

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

Andrew R. Zolopa, Janet Andersen, Lauren Komarow, Ian M. Sanne, Alejandro Sanchez, Evelyn Hogg, Carol Suckow, William G. Powderly. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. Public Library of Science One. 2009. 4: e5575. PMID: 19440326

Year

2009

Journal

Public Library of Science One

Effect of early versus deferred antiretroviral therapy for HIV on survival

Marina B. Klein, Rosemary G. McKaig, Lisa P. Jacobson, Bryan Lau, Mari M. Kitahata, Benigno Rodriguez, Aimee M. Freeman, Stephen J. Gange, Timothy R. Sterling, Richard D. Moore, Alison A. Abraham, Gregory D. Kirk, Barry Merriman, Sonia Napravnik, Michael Switow Saag, Anita Rachlis, Amy C. Justice, Liviana M. Calzavara, Robert S. Hogg, Michael Horberg, Steven G. Deeks, Michael J. Silverberg, Joseph J. Eron, Kelly A. Gebo, John Brooks, James J. Goedert, Sean B. Rourke, Constance A. Benson, M. John Gill, Ann C. Collier, Ronald J. Bosch, Stephen E. Van Rompaey, Jeffrey N. Martin, Heidi M. Crane. Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine. 2009. 360: 1815-26.

Year

2009

Journal

New England Journal of Medicine

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease

Patricia Price, Ian James. IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease. AIDS. 2009. 23: 1173-6.

Year

2009

Journal

AIDS